A Multiplex Test Assessing MiR663a(me) and VIM(me) in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions

Bladder cancer (BlCa) is a common malignancy with significant morbidity and mortality. Current diagnostic methods are invasive and costly, showing the need for newer biomarkers. Although several epigenetic-based biomarkers have been proposed, their ability to discriminate BlCa from common benign con...

Descripción completa

Detalles Bibliográficos
Autores principales: Monteiro-Reis, Sara, Blanca, Ana, Tedim-Moreira, Joana, Carneiro, Isa, Montezuma, Diana, Monteiro, Paula, Oliveira, Jorge, Antunes, Luís, Henrique, Rui, Lopez-Beltran, António, Jerónimo, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073678/
https://www.ncbi.nlm.nih.gov/pubmed/32102337
http://dx.doi.org/10.3390/jcm9020605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073678/
https://www.ncbi.nlm.nih.gov/pubmed/32102337
http://dx.doi.org/10.3390/jcm9020605

Ejemplares similares